Coronary Artery Restenosis Completed Phase 4 Trials for Sirolimus (DB00877)

Also known as: Restenosis, Coronary / Coronary Restenosis

IndicationStatusPhase
DBCOND0032386 (Coronary Artery Restenosis)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00552669Study of Oral Rapamycin Plus Bare Metal Stents vs Drug Eltuting StentsHealth Services Research
NCT00859183Oral Sirolimus for In-Stent RestenosisTreatment